Tci Wealth Advisors, Inc. Genprex, Inc. Transaction History

Tci Wealth Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$1.21 - $2.7 $242 - $540	-200 Reduced 40.0%	300 $0
Q4 2020 Jan 21, 2021	SELL	$3.03 - $5.51 $439 - $798	-145 Reduced 22.48%	500 $2,000
Q3 2020 Oct 20, 2020	BUY	$2.9 - $4.29 $420 - $622	145 Added 29.0%	645 $2,000
Q1 2020 Apr 14, 2020	BUY	$0.28 - $6.23 $140 - $3,115	500 New	500 $1,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.